1 |
Gavadia R, Rasgania J, Basil MV, Chauhan V, Kumar S, Jakhar K. Synthesis of Isoniazid analogs with Promising Antituberculosis Activity and Bioavailability: Biological Evaluation and Computational Studies. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.135325] [Reference Citation Analysis]
|
2 |
Sarah Abdul-razzaq makki, Shakir M Alwan, Mayada H. Al-qaissy. In Silico Molecular Docking, Synthesis and Preliminary Evaluation of Antibacterial Activity of Levofloxacin Carboxamides with Certain Amino Acids. AJPS 2023;23:22-32. [DOI: 10.32947/ajps.v23i1.984] [Reference Citation Analysis]
|
3 |
Gao J, Hou H, Gao F. Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens. Eur J Med Chem 2023;247:115026. [PMID: 36577217 DOI: 10.1016/j.ejmech.2022.115026] [Reference Citation Analysis]
|
4 |
Mahjoore M, Honarmand M, Aryafar A. Plant-based green fabrication of CuO-CdO-bentonite S-scheme heterojunction with enhanced photocatalytic performance for the degradation of levofloxacin. Environ Sci Pollut Res Int 2023. [PMID: 36692716 DOI: 10.1007/s11356-023-25277-1] [Reference Citation Analysis]
|
5 |
Lukin A, Komarova K, Vinogradova L, Rogacheva E, Kraeva L, Krasavin M. Synthesis and Antibacterial Evaluation of Ciprofloxacin Congeners with Spirocyclic Amine Periphery. Int J Mol Sci 2023;24. [PMID: 36674469 DOI: 10.3390/ijms24020954] [Reference Citation Analysis]
|
6 |
Aslam B, Ahmad M, Tariq MU, Muzammil S, Siddique AB, Khurshid M, Shahid A, Rasool MH, Chaudhry TH, Amir A, Salman M, Baloch Z. Antibiotic resistance: retrospect and prospect. Degradation of Antibiotics and Antibiotic-Resistant Bacteria from Various Sources 2023. [DOI: 10.1016/b978-0-323-99866-6.00008-8] [Reference Citation Analysis]
|
7 |
Butylchenko O, Ermakov D, Babaskin D. Pharmacokinetic properties of Fluoroquinolones in Comparative Aspect of their effect on Pathogenic microflora. RJPT 2022. [DOI: 10.52711/0974-360x.2022.00979] [Reference Citation Analysis]
|
8 |
Prathapan P. Magic bullets, magic shields, and antimicrobials in between. Pharmaceutical Science Advances 2022. [DOI: 10.1016/j.pscia.2022.100002] [Reference Citation Analysis]
|
9 |
Cardoso-ortiz J, Leyva-ramos S, Baines KM, Gómez-durán CFA, Hernández-lópez H, Palacios-can FJ, Valcarcel-gamiño JA, Leyva-peralta MA, Razo-hernández RS. Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: targeting S. aureus topoisomerase and SARS-CoV-2-MPro. Journal of Molecular Structure 2022. [DOI: 10.1016/j.molstruc.2022.134507] [Reference Citation Analysis]
|
10 |
Mohammed HHH, Ali DME, Badr M, Habib AGK, Mahmoud AM, Farhan SM, Gany SSHAE, Mohamad SA, Hayallah AM, Abbas SH, Abuo-Rahma GEA. Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors. Mol Divers 2022. [PMID: 36152132 DOI: 10.1007/s11030-022-10528-z] [Reference Citation Analysis]
|
11 |
Ben Ayed A, Akrout I, Albert Q, Greff S, Simmler C, Armengaud J, Kielbasa M, Turbé-doan A, Chaduli D, Navarro D, Bertrand E, Faulds CB, Chamkha M, Maalej A, Zouari-mechichi H, Sciara G, Mechichi T, Record E. Biotransformation of the Fluoroquinolone, Levofloxacin, by the White-Rot Fungus Coriolopsis gallica. JoF 2022;8:965. [DOI: 10.3390/jof8090965] [Reference Citation Analysis]
|
12 |
Lungu IA, Moldovan OL, Biriș V, Rusu A. Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance. Pharmaceutics 2022;14:1749. [PMID: 36015376 DOI: 10.3390/pharmaceutics14081749] [Reference Citation Analysis]
|
13 |
Tan YM, Li D, Li FF, Fawad Ansari M, Fang B, Zhou CH. Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents. Bioorg Med Chem Lett 2022;73:128885. [PMID: 35835379 DOI: 10.1016/j.bmcl.2022.128885] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
14 |
Simon AT, Chattopadhyay A, Ghosh SS. In Vitro Therapeutic Attributes of Luminescent Hydroxyapatite Nanoparticles in Codelivery Module. ACS Appl Bio Mater 2022. [PMID: 35608933 DOI: 10.1021/acsabm.2c00201] [Reference Citation Analysis]
|
15 |
Varkhedkar R, Yang F, Dontha R, Zhang J, Liu J, Spingler B, van der Veen S, Duttwyler S. Natural-Product-Directed Catalytic Stereoselective Synthesis of Functionalized Fused Borane Cluster-Oxazoles for the Discovery of Bactericidal Agents. ACS Cent Sci 2022;8:322-31. [PMID: 35350606 DOI: 10.1021/acscentsci.1c01132] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
16 |
Ramakrishna C, Subbareddy G. Synthesis Docking Studies and Antitubercular Activity of Ofloxacin Scaffold using Blanc Reaction. Asian J Chem 2022;34:644-650. [DOI: 10.14233/ajchem.2022.23584] [Reference Citation Analysis]
|
17 |
Luo X. Mechanism of levofloxacin, tobramycin, and azithromycin in the treatment of bacterial conjunctivitis. 7TH INTERNATIONAL CONFERENCE ON MATHEMATICS: PURE, APPLIED AND COMPUTATION: Mathematics of Quantum Computing 2022. [DOI: 10.1063/5.0113013] [Reference Citation Analysis]
|
18 |
Rezaee E, Nazari M, Mosayebnia M, Movahed MA. Novel medicinal and synthetic chemistry strategies against antimicrobial resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 2022. [DOI: 10.1016/b978-0-323-90792-7.00017-8] [Reference Citation Analysis]
|
19 |
López Y, Muñoz L, Gargallo-Viola D, Cantón R, Vila J, Zsolt I. Uptake of Ozenoxacin and Other Quinolones in Gram-Positive Bacteria. Int J Mol Sci 2021;22:13363. [PMID: 34948159 DOI: 10.3390/ijms222413363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
20 |
Sousa ME, Marques MM, Faustino MAF. 1st Spring Virtual Meeting on Medicinal Chemistry. Chemistry Proceedings 2021. [DOI: 10.3390/chemproc2021004001] [Reference Citation Analysis]
|
21 |
Aziz HA, El-Saghier AMM, Badr M, Abuo-Rahma GEA, Shoman ME. Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities. Mol Divers 2021. [PMID: 34455532 DOI: 10.1007/s11030-021-10302-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
22 |
Aura Rusu, Ioana-Andreea Lungu, Octavia-Laura Moldovan, Corneliu Tanase, Gabriel Hancu. Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones—Shaping the Fifth Generation. Pharmaceutics 2021;13:1289. [PMID: 34452252 DOI: 10.3390/pharmaceutics13081289] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
|
23 |
Desiatkina O, Johns SK, Anghel N, Boubaker G, Hemphill A, Furrer J, Păunescu E. Synthesis and Antiparasitic Activity of New Conjugates—Organic Drugs Tethered to Trithiolato-Bridged Dinuclear Ruthenium(II)–Arene Complexes. Inorganics 2021;9:59. [DOI: 10.3390/inorganics9080059] [Reference Citation Analysis]
|
24 |
Alaaeldin R, Mustafa M, Abuo-Rahma GEA, Fathy M. In vitro inhibition and molecular docking of a new ciprofloxacin-chalcone against SARS-CoV-2 main protease. Fundam Clin Pharmacol 2021. [PMID: 34268806 DOI: 10.1111/fcp.12708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
25 |
Reyhane Rahimpour, Sabeti B, Chekin F. Electrochemical Sensor Based on Nitrogen Doped Porous Reduced Graphene Oxide to Detection of Ciprofloxacin in Pharmaceutical Samples. Russ J Electrochem 2021;57:654-62. [DOI: 10.1134/s1023193520120186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
26 |
Alegun O, Pandeya A, Cui J, Ojo I, Wei Y. Donnan Potential across the Outer Membrane of Gram-Negative Bacteria and Its Effect on the Permeability of Antibiotics. Antibiotics (Basel) 2021;10:701. [PMID: 34208097 DOI: 10.3390/antibiotics10060701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
27 |
Ching C, Zaman MH. Impact of ciprofloxacin impurities on bacterial growth, antibiotic resistance development and content assays. Lett Appl Microbiol 2021;73:220-8. [PMID: 33905563 DOI: 10.1111/lam.13494] [Reference Citation Analysis]
|
28 |
de Faria LV, Lisboa TP, Campos NDS, Alves GF, Matos MAC, Matos RC, Munoz RAA. Electrochemical methods for the determination of antibiotic residues in milk: A critical review. Anal Chim Acta 2021;1173:338569. [PMID: 34172150 DOI: 10.1016/j.aca.2021.338569] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
|
29 |
Surur AS, Sun D. Macrocycle-Antibiotic Hybrids: A Path to Clinical Candidates. Front Chem 2021;9:659845. [PMID: 33996753 DOI: 10.3389/fchem.2021.659845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
30 |
Gultekin E, Bekircan O, Kolcuoğlu Y, Akdemir A. Synthesis of new 1,2,4-triazole-(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis. Arch Pharm (Weinheim) 2021;354:e2100058. [PMID: 33900640 DOI: 10.1002/ardp.202100058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
31 |
Al-Wahaibi LH, Amer AA, Marzouk AA, Gomaa HAM, Youssif BGM, Abdelhamid AA. Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors. Pharmaceuticals (Basel) 2021;14:399. [PMID: 33922361 DOI: 10.3390/ph14050399] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
32 |
Hou D, Wang R, Wang Z, Yang G, Xu Z, Zeng Q, Chen Y. A light-activatable antibiotic with high activation efficiency and uncompromised bactericidal potency in the activated state. J Leather Sci Eng 2021;3. [DOI: 10.1186/s42825-021-00051-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
33 |
Verma K, Mahalapbutr P, Suriya U, Somboon T, Aiebchun T, Shi L, Maitarad P, Rungrotmongkol T. In Silico Screening of DNA Gyrase B Potent Flavonoids for the Treatment of Clostridium difficile Infection from PhytoHub Database. Braz arch biol technol 2021;64:e21200402. [DOI: 10.1590/1678-4324-2021200402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
34 |
Bremner J. Single Molecule Non-cleavable Multiply Active Antibacterials. Multiple Action-Based Design Approaches to Antibacterials 2021. [DOI: 10.1007/978-981-16-0999-2_3] [Reference Citation Analysis]
|
35 |
Periyan D, Chinnasamy U. Maleimide-g-pyridine Octadecene Polymers: Synthesis, Characterization, Thermal Stability, Fluorescence and Biological Studies. Asian J Chem 2021;33:459-464. [DOI: 10.14233/ajchem.2021.22549] [Reference Citation Analysis]
|
36 |
Bokhtia RM, Panda SS, Girgis AS, Honkanadavar HH, Ibrahim TS, George RF, Kashef MT, Fayad W, Sakhuja R, Abdel-aal EH, Al-mahmoudy AMM. Fluoroquinolone-3-carboxamide Amino Acid Conjugates: Synthesis, Antibacterial Properties And Molecular Modeling Studies. MC 2020;17:71-84. [DOI: 10.2174/1573406415666190904143852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
37 |
Dalhoff A. Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks? Infection 2021;49:29-56. [PMID: 33367978 DOI: 10.1007/s15010-020-01536-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
38 |
Ali S, Khan MT, Khan AS, Abbas Q, Irfan M. Fluoroquinolone Resistance Among Isolates of Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. Microb Drug Resist 2021;27:786-91. [PMID: 33124944 DOI: 10.1089/mdr.2020.0118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
39 |
Marciniec K, Beberok A, Pęcak P, Boryczka S, Wrześniok D. Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis. Pharmacol Rep 2020;72:1553-61. [PMID: 33063271 DOI: 10.1007/s43440-020-00169-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
|
40 |
Kraft O, Kozubek M, Hoenke S, Serbian I, Major D, Csuk R. Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum. Eur J Med Chem 2021;209:112920. [PMID: 33049606 DOI: 10.1016/j.ejmech.2020.112920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
41 |
Martins Santos OM, Jacon Freitas JT, Bitencourt M, Martins FT, Doriguetto AC. Three new orbifloxacin multicomponent crystal forms towards pharmaceutical improvement†. Journal of Molecular Structure 2020;1217:128371. [DOI: 10.1016/j.molstruc.2020.128371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
42 |
Kasabri V, Arabiyat S, Al-hiari Y, Zalloum H, Almaliti J, Telfah A, Bustanji YK, Alalawi S. Fluoroquinolones as a potentially novel class of antidiabesity and antiproliferative compounds: synthesis and docking studies. Can J Chem 2020;98:635-45. [DOI: 10.1139/cjc-2020-0162] [Reference Citation Analysis]
|
43 |
Ciura K, Fedorowicz J, Kapica H, Adamkowska A, Sawicki W, Sączewski J. Affinity of Fluoroquinolone–Safirinium Dye Hybrids to Phospholipids Estimated by IAM-HPLC. Processes 2020;8:1148. [DOI: 10.3390/pr8091148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
44 |
Sharma P, Goyal R, Sharma A, Sharma D, Saini N, Rajak H, Sharma S, Thakur V. Insights on fluoroquinolones in cancer therapy: chemistry and recent developments. Materials Today Chemistry 2020;17:100296. [DOI: 10.1016/j.mtchem.2020.100296] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
45 |
Shahzad SA, Sarfraz A, Yar M, Khan ZA, Naqvi SAR, Naz S, Khan NA, Farooq U, Batool R, Ali M. Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs. Bioorg Chem 2020;100:103876. [PMID: 32388426 DOI: 10.1016/j.bioorg.2020.103876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
46 |
Vergalli J, Atzori A, Pajovic J, Dumont E, Malloci G, Masi M, Vargiu AV, Winterhalter M, Réfrégiers M, Ruggerone P, Pagès JM. The challenge of intracellular antibiotic accumulation, a function of fluoroquinolone influx versus bacterial efflux. Commun Biol 2020;3:198. [PMID: 32346058 DOI: 10.1038/s42003-020-0929-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
47 |
AlKhalil M, Al-Hiari Y, Kasabri V, Arabiyat S, Al-Zweiri M, Mamdooh N, Telfah A. Selected pharmacotherapy agents as antiproliferative and anti-inflammatory compounds. Drug Dev Res 2020;81:470-90. [PMID: 31943302 DOI: 10.1002/ddr.21640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
48 |
Gupta V, Datta P. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids. Indian J Med Res 2019;149:97-106. [PMID: 31219074 DOI: 10.4103/ijmr.IJMR_755_18] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
|
49 |
Beebe SJ, Celestine MJ, Bullock JL, Sandhaus S, Arca JF, Cropek DM, Ludvig TA, Foster SR, Clark JS, Beckford FA, Tano CM, Tonsel-White EA, Gurung RK, Stankavich CE, Tse-Dinh YC, Jarrett WL, Holder AA. Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligand. J Inorg Biochem 2020;203:110907. [PMID: 31715377 DOI: 10.1016/j.jinorgbio.2019.110907] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
50 |
Bogdanov AV, Zaripova IF, Voloshina AD, Sapunova AS, Kulik NV, Tsivunina IV, Dobrynin AB, Mironov VF. Isatin derivatives bearing a fluorine atom. Part 1: Synthesis, hemotoxicity and antimicrobial activity evaluation of fluoro-benzylated water-soluble pyridinium isatin-3-acylhydrazones. Journal of Fluorine Chemistry 2019;227:109345. [DOI: 10.1016/j.jfluchem.2019.109345] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
|
51 |
Lien VT, Olberg DE, Hagelin G, Klaveness J. Synthesis and antiproliferative evaluation of novel N-arylquinolones. Monatsh Chem 2019;150:1947-57. [DOI: 10.1007/s00706-019-02504-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
52 |
Zhang J, Wang S, Ba Y, Xu Z. 1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents. European Journal of Medicinal Chemistry 2019;174:1-8. [DOI: 10.1016/j.ejmech.2019.04.033] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 16.3] [Reference Citation Analysis]
|
53 |
Fedorowicz J, Sączewski J, Konopacka A, Waleron K, Lejnowski D, Ciura K, Tomašič T, Skok Ž, Savijoki K, Morawska M, Gilbert-Girard S, Fallarero A. Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents. Eur J Med Chem 2019;179:576-90. [PMID: 31279292 DOI: 10.1016/j.ejmech.2019.06.071] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 10.5] [Reference Citation Analysis]
|
54 |
Sevillano M, Dai Z, Calus S, Bautista-de los Santos QM, Eren AM, van der Wielen PW, Ijaz UZ, Pinto AJ. Disinfectant residuals in drinking water systems select for mycobacterial populations with intrinsic antimicrobial resistance.. [DOI: 10.1101/675561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
55 |
Zhang B. Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids. European Journal of Medicinal Chemistry 2019;168:357-72. [DOI: 10.1016/j.ejmech.2019.02.055] [Cited by in Crossref: 119] [Cited by in F6Publishing: 98] [Article Influence: 29.8] [Reference Citation Analysis]
|